BILIBILI INC-SPONSORED ADR
BILINASDAQ🏆 #2502 by market capEarnings Nov 12US Equity
$12.83▼ $0.07 (−0.58%)
Latest quoteTrack BILI
Get earnings, price moves & breaking news on Telegram
24h▼ 0.6%
7d▼ 4.9%
14d▼ 11.2%
30d▼ 13.5%
ytd▼ 47.9%
1y▼ 59.9%
🏦Market Cap
$5.39B
Small Cap
📈Revenue Growth (YoY)
6.9%
Slowing
📊Gross Margin
37.0%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
1.2x
Cheap
Otter Score
60
Fair
BILIBILI INC-SPONSORED ADR
BILIAnalyst Ratings
Price
$12.83
Total
24
Raised
7
Lowered
2
Avg PT
$27.25
H / L
$30 / $23
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Citigroup | Reiterated | Buy | 2026-10-14 | $18.00 | +40.40% |
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2026-04-13 | $27.00 | +110.50% |
JP Morgan | Upgraded | Neutral → Overweight | 2026-03-17 | — | — |
B of A Securities | Reiterated | Buy | 2025-11-28 | — | — |
Barclays | Reiterated | Overweight | 2025-11-14 | $34.00 | +165.10% |
Benchmark | Reiterated | Buy | 2025-11-14 | — | — |
Bernstein | Reiterated | Outperform | 2025-10-23 | $32.00 | +149.50% |
HSBC | Upgraded | Hold → Buy | 2025-05-21 | — | — |
Mizuho | Reiterated | Outperform | 2024-11-12 | — | — |
Nomura | Upgraded | Neutral → Buy | 2024-08-22 | $18.00 | +40.40% |
UBS | Upgraded | Neutral → Buy | 2024-05-31 | $18.00 | +40.40% |
CLSA | Reiterated | Outperform → Buy | 2024-05-10 | $16.80 | +31.00% |
Goldman Sachs | Reiterated | Neutral | 2023-11-30 | $22.60 | +76.20% |
Baird | Reiterated | Neutral | 2023-08-18 | — | — |
Deutsche Bank | Reiterated | Buy | 2021-08-13 | $110.00 | +757.70% |
86 Research | Upgraded | Hold → Buy | 2021-05-14 | — | — |
Credit Suisse | Upgraded | Neutral → Outperform | 2021-04-08 | $139.00 | +983.80% |
Nomura Instinet | Downgraded | Buy → Neutral | 2020-08-27 | — | — |
BOCOM International | Downgraded | Buy → Neutral | 2020-07-17 | — | — |
Citi | Reiterated | Buy | 2019-08-27 | — | — |
Jefferies | Reiterated | Buy | 2019-08-05 | $28.00 | +118.30% |
China Renaissance | Reiterated | Buy | 2019-02-27 | — | — |
Daiwa Capital | Reiterated | Outperform | 2019-01-14 | — | — |
Bank of America | Reiterated | Buy | 2018-09-11 | — | — |
Institution
Citigroup
Reiterated · Buy · 2026-10-14
$18.00
+40.40%
Morgan Stanley
Upgraded · Equal Weight → Overweight · 2026-04-13
$27.00
+110.50%
JP Morgan
Upgraded · Neutral → Overweight · 2026-03-17
—
—
B of A Securities
Reiterated · Buy · 2025-11-28
—
—
Barclays
Reiterated · Overweight · 2025-11-14
$34.00
+165.10%
Benchmark
Reiterated · Buy · 2025-11-14
—
—
Bernstein
Reiterated · Outperform · 2025-10-23
$32.00
+149.50%
HSBC
Upgraded · Hold → Buy · 2025-05-21
—
—
Mizuho
Reiterated · Outperform · 2024-11-12
—
—
Nomura
Upgraded · Neutral → Buy · 2024-08-22
$18.00
+40.40%
UBS
Upgraded · Neutral → Buy · 2024-05-31
$18.00
+40.40%
CLSA
Reiterated · Outperform → Buy · 2024-05-10
$16.80
+31.00%
Goldman Sachs
Reiterated · Neutral · 2023-11-30
$22.60
+76.20%
Baird
Reiterated · Neutral · 2023-08-18
—
—
Deutsche Bank
Reiterated · Buy · 2021-08-13
$110.00
+757.70%
86 Research
Upgraded · Hold → Buy · 2021-05-14
—
—
Credit Suisse
Upgraded · Neutral → Outperform · 2021-04-08
$139.00
+983.80%
Nomura Instinet
Downgraded · Buy → Neutral · 2020-08-27
—
—
BOCOM International
Downgraded · Buy → Neutral · 2020-07-17
—
—
Citi
Reiterated · Buy · 2019-08-27
—
—
Jefferies
Reiterated · Buy · 2019-08-05
$28.00
+118.30%
China Renaissance
Reiterated · Buy · 2019-02-27
—
—
Daiwa Capital
Reiterated · Outperform · 2019-01-14
—
—
Bank of America
Reiterated · Buy · 2018-09-11
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space